| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 13/03/18 | | 14:10:02 | 13 Mar 2018 | | | Annual Financial Report | GlaxoSmithKline PLC | RNS |
| 12/03/18 | | 16:30:58 | 12 Mar 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/03/18 | | 08:00:02 | 8 Mar 2018 | | | GSK announces labelling update to Relvar Ellipta | GlaxoSmithKline PLC | RNS |
| 05/03/18 | | 17:01:47 | 5 Mar 2018 | | | ViiV Healthcare announces new dolutegravir data | GlaxoSmithKline PLC | RNS |
| 05/03/18 | | 14:47:21 | 5 Mar 2018 | | | Nucala OSMO study presented at AAAAI-WAO congress | GlaxoSmithKline PLC | RNS |
| 05/03/18 | | 12:04:08 | 5 Mar 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/03/18 | | 13:11:15 | 2 Mar 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/03/18 | | 11:16:56 | 1 Mar 2018 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 22/02/18 | | 16:54:01 | 22 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/02/18 | | 13:17:51 | 20 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/02/18 | | 13:16:18 | 20 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/02/18 | | 13:15:48 | 20 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/02/18 | | 18:12:41 | 19 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/02/18 | | 17:29:44 | 16 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/02/18 | | 17:25:38 | 16 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/02/18 | | 11:20:41 | 16 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/02/18 | | 18:09:36 | 15 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/02/18 | | 17:57:11 | 15 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/02/18 | | 17:53:31 | 15 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/02/18 | | 09:00:43 | 14 Feb 2018 | | | GSK submits landmark IMPACT data - Trelegy Ellipta | GlaxoSmithKline PLC | RNS |
| 13/02/18 | | 16:44:11 | 13 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/02/18 | | 14:43:49 | 12 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/02/18 | | 12:47:23 | 12 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/02/18 | | 09:31:08 | 8 Feb 2018 | | | ViiV Healthcare launches new two-drug HIV study | GlaxoSmithKline PLC | RNS |
| 08/02/18 | | 07:00:02 | 8 Feb 2018 | | | ViiV files patent infringement litigation | GlaxoSmithKline PLC | RNS |
| 07/02/18 | | 13:19:18 | 7 Feb 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 07/02/18 | | 12:01:02 | 7 Feb 2018 | | | Final Results | GlaxoSmithKline PLC | RNS |
| 07/02/18 | | 09:04:55 | 7 Feb 2018 | | | GSK's Bexsero FDA Breakthrough Therapy Designation | GlaxoSmithKline PLC | RNS |
| 01/02/18 | | 11:52:13 | 1 Feb 2018 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 26/01/18 | | 12:30:04 | 26 Jan 2018 | | | GSK's Shingrix - positive CHMP opinion in Europe | GlaxoSmithKline PLC | RNS |
| 26/01/18 | | 09:00:01 | 26 Jan 2018 | | | GSK's Relvar Ellipta - positive CHMP opinion | GlaxoSmithKline PLC | RNS |
| 23/01/18 | | 15:22:44 | 23 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/01/18 | | 17:19:13 | 19 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/01/18 | | 17:17:05 | 19 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/01/18 | | 17:48:24 | 16 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/01/18 | | 17:59:59 | 15 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/01/18 | | 17:54:36 | 15 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/01/18 | | 17:34:31 | 15 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/01/18 | | 09:18:11 | 15 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/01/18 | | 09:04:55 | 15 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/01/18 | | 15:33:45 | 11 Jan 2018 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/01/18 | | 14:00:08 | 2 Jan 2018 | | | Director Shareholding | GlaxoSmithKline PLC | RNS |
| 02/01/18 | | 13:54:15 | 2 Jan 2018 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 21/12/17 | | 09:02:53 | 21 Dec 2017 | | | FDA approval - on ICS/LABA combinations in asthma | GlaxoSmithKline PLC | RNS |
| 18/12/17 | | 16:21:15 | 18 Dec 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/12/17 | | 07:00:04 | 15 Dec 2017 | | | Transfer of Shares out of Treasury | GlaxoSmithKline PLC | RNS |
| 12/12/17 | | 16:50:14 | 12 Dec 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |